These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 30955388)
21. [Clinical and pathologic characteristics of small cell neuroendocrine carcinoma of urinary tract]. Guo AT; Chen W; Wei LX Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):747-51. PubMed ID: 23302335 [TBL] [Abstract][Full Text] [Related]
22. High-grade neuroendocrine carcinoma of the urachus-report of 3 cases. Wang G; Huang H; Kamat AM; Siefker-Radtke A; Dinney CP; Troncoso P; Czerniak B; Guo CC Hum Pathol; 2017 Sep; 67():126-133. PubMed ID: 28823575 [TBL] [Abstract][Full Text] [Related]
23. Villous Adenoma Arising in the Native Bladder Mucosa and the Upper Urinary Tract With Coexisting Neuroendocrine Carcinoma Following Augmentation Cystoplasty. Nayak A; Depasquale B; Vergara N; Guzzo TA; Lal P Int J Surg Pathol; 2019 Jun; 27(4):450-456. PubMed ID: 30701999 [TBL] [Abstract][Full Text] [Related]
24. [A case of neuroendocrine carcinoma in a diverticulum of the bladder]. Muramatsu H; Kanao K; Morinaga S; Kajikawa K; Kobayashi I; Nishikawa G; Yoshizawa T; Kato Y; Watanabe M; Zennami K; Nakamura K; Sumitomo M Hinyokika Kiyo; 2014 Sep; 60(9):439-42. PubMed ID: 25293798 [TBL] [Abstract][Full Text] [Related]
25. Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine-nonneuroendocrine neoplasm. Sun L; Zhang J; Wang C; Zhao S; Shao B; Guo Y; Liu Y; Sun Y Mod Pathol; 2020 Dec; 33(12):2602-2613. PubMed ID: 32461621 [TBL] [Abstract][Full Text] [Related]
26. "Pure" primary large cell neuroendocrine carcinoma of the urinary bladder: case report, literature review and diagnostic criteria. Pusiol T; Morichetti D; Zorzi MG Pathologica; 2014 Jun; 106(2):82-5. PubMed ID: 25291874 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Wang HL; Lu DW; Yerian LM; Alsikafi N; Steinberg G; Hart J; Yang XJ Am J Surg Pathol; 2001 Nov; 25(11):1380-7. PubMed ID: 11684954 [TBL] [Abstract][Full Text] [Related]
28. [Neuroendocrine cell carcinoma of the urinary bladder: a case report]. Mikami K; Ito H; Masai M; Kotake T; Sugano I; Nagao K Hinyokika Kiyo; 1996 Jul; 42(7):529-31. PubMed ID: 8809564 [TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and substaging of pT1 bladder cancer]. Cheng L; Huang WB; Zheng SQ; Zheng J Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):636-9. PubMed ID: 18070458 [No Abstract] [Full Text] [Related]
31. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Oliva E; Amin MB; Jimenez R; Young RH Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940 [TBL] [Abstract][Full Text] [Related]
32. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Guo CC; Fine SW; Epstein JI Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332 [TBL] [Abstract][Full Text] [Related]
33. [Neuroendocrine carcinoma of the urinary bladder:clinicopathologic features analysis of 17 cases]. Jiang Y; Yu W; Zhang W; Li Y; Lu Q; Liu Y; Li H; Hou F; Li J; Zhuang J Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):736-41. PubMed ID: 25582251 [TBL] [Abstract][Full Text] [Related]
34. Treatment and outcomes of urethral recurrence of urinary bladder cancer in women after radical cystectomy and orthotopic neobladder: a series of 12 cases. Hrbáček J; Macek P; Ali-El-Dein B; Thalmann GN; Stenzl A; Babjuk M; Shaaban AA; Gakis G Urol Int; 2015; 94(1):45-9. PubMed ID: 25171129 [TBL] [Abstract][Full Text] [Related]
35. Mixed adenoneuroendocrine carcinoma of the gallbladder, amphicrine type: Case report and review of literature. Zhang D; Li P; Szankasi P; Liao X Pathol Res Pract; 2020 Jul; 216(7):152997. PubMed ID: 32534704 [TBL] [Abstract][Full Text] [Related]
36. Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary Bladder. Garczyk S; Ortiz-Brüchle N; Schneider U; Lurje I; Guricova K; Gaisa NT; Lorsy E; Lindemann-Docter K; Heidenreich A; Knüchel R Am J Pathol; 2020 Feb; 190(2):323-332. PubMed ID: 31734230 [TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine liver metastasis in gastric mixed adenoneuroendocrine carcinoma with trilineage cell differentiation: a case report. Zhang W; Xiao W; Ma H; Sun M; Chen H; Zheng S Int J Clin Exp Pathol; 2014; 7(9):6333-8. PubMed ID: 25337287 [TBL] [Abstract][Full Text] [Related]
38. Mixed exocrine-neuroendocrine carcinoma of the nasal cavity: clinico-pathologic and molecular study of a case and review of the literature. La Rosa S; Furlan D; Franzi F; Battaglia P; Frattini M; Zanellato E; Marando A; Sahnane N; Turri-Zanoni M; Castelnuovo P; Capella C Head Neck Pathol; 2013 Mar; 7(1):76-84. PubMed ID: 22740238 [TBL] [Abstract][Full Text] [Related]
39. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness. Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799 [TBL] [Abstract][Full Text] [Related]
40. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract. Helpap B Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]